Sorry Rappers, page-216

Disagree, they clearly state they have enough funds for the second clinical trials in the US in 12 months time, their capital expenditure was $5.4M last year (and it was $1.8M last quarter and the previous quarter) but you got to remember $3.2M was on R&D (supposedly you can reclaim tax refund on that).......and with still $8.5M cash on hand this isn't an issue. If they need to raise more CR in the future, they need to regain market confidence in the next 12 month and they have enough cash on hand to do this and to get the pps back to 20c (from memory this was the price they did their last CR).

I wouldn't even worry about the cost associated with the Teleheath, the pps will be 50c+ at this stage.........